⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2024Translational Lung Cancer ResearchOpen Access

Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma

Weiran Liu Chen Chen Qiang Zhang Jiping Xie Xinyi Wu Zhenfa Zhang Lin Shao Haiwei Du Songan Chen Hirokazu Iso Kakeru Hisakane Dongsheng Yue Bin Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

The benefit of adjuvant therapy remains controversial in completely resected (R0) stage IB non-small cell lung cancer (NCLSC) patients. In this study, we aimed to explore potential prognostic factors in stage IB NSCLC patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e59f9eb6db643587539afa https://doi.org/10.21037/tlcr-24-506

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinicopathologic Predictors of Outcome and Implications for Adjuvant Therapy in Pathologic Stage II Non-small Cell Lung CancerRetrospective Study · 2026
2Establishment and validation of a clinicopathological prediction model for postoperative recurrence of stage IA lung adenocarcinoma2024
3Survival after Surgery in Stage IA and IB Non–Small Cell Lung CancerPrognostic Study · 2007 · 75 citations
4The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study2024 · 6 citations
5Prognostic significance of micropapillary pattern and risk factors in patients with resected stage I lung adenocarcinoma and possible benefit of adjuvant therapy: a real-world multicenter study2025

[Selection of postoperative adjuvant therapy for patients with stage IB lung adenocarcinoma: analysis of 653 cases].2024
Analysis of risk factors for postoperative recurrence of stage IA lung adenocarcinoma2025
Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection2024
Perioperative safety and risk stratification of simultaneous resection for multiple pulmonary nodules via video-assisted thoracoscopic surgery: a retrospective cohort studyTranslational Lung Cancer Research · 2026
Predictors of prolonged hospital stay in patients with lung cancer undergoing sublobar resectionTranslational Lung Cancer Research · 2026

More from Translational Lung Cancer Research

More from Nippon Medical School

More from Tianjin Medical University Cancer Institute and Hospital

More from Burning Rock Biotech (China)